Strides Pharma Science Ltd Financials Statements

Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

Consolidate
Standalone
Financial Year
Dec '24
Sep '24
Jun '24
Mar '24
Dec '23
Total Qtr Revenue cr
1,159.28
1,229.52
1,100.22
1,070.49
1,046.42
Other Income Qtr Cr5.6228.4112.72-13.558.75
Operating Revenues Qtr1,153.671,201.111,087.501,084.041,037.67

*All values are in Cr.

Operating Expenses Qtr
943.36
965.30
870.52
854.30
843.86
Operating Profit Qtr
210.31
235.81
216.98
229.73
193.81
EBIDT Qtr Cr
213.50
260.35
225.96
208.19
246.65
Depreciation Qtr
48.42
50.52
48.59
49.76
51.23
Net Profit Qtr
87.95
93.23
70.20
18.18
49.67
Basic EPS Qtr
9.56
10.14
7.64
1.98
5.43
Open Demat Account
+91 -

personImage
Open Demat Account
+91 -